Literature DB >> 23033269

SOCS3 promotes interleukin-17 expression of human T cells.

Katja Kleinsteuber1, Kerrin Heesch, Stefanie Schattling, Claudia Sander-Juelch, Ulrike Mock, Kristoffer Riecken, Boris Fehse, Bernhard Fleischer, Marc Jacobsen.   

Abstract

SOCS3 is a feedback regulator of cytokine signaling that affects T-cell polarization. Human tuberculosis is accompanied by increased SOCS3 expression in T cells, and this may influence susceptibility against Mycobacterium tuberculosis. Because the role of SOCS3 in human T-cell function is not well defined, we characterized cytokine expression and proliferation of human T cells with differential SOCS3 expression in the present study. We established a flow cytometry-based method for SOCS3 protein quantification and detected higher SOCS3 levels induced by M tuberculosis specific T-cell activation and a transient decrease of SOCS3 expression in the presence of mycobacteria-infected macrophages. Notably increased SOCS3 expression was detected in IL-17-expressing T-cell clones and in CD161(+) T helper type 17 cells ex vivo. Ectopic SOCS3 expression in primary CD4(+) T cells by lentiviral transduction induced increased IL-17 production but diminished proliferation and viability. Recombinant IL-7 inhibited SOCS3 expression and reduced IL-17-expressing T-cell proportions. We concluded that higher SOCS3 expression in human T cells favors T helper type 17 cells. Therefore, increased SOCS3 expression in human tuberculosis may reflect polarization toward IL-17-expressing T cells as well as T-cell exhaustion marked by reduced proliferation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23033269     DOI: 10.1182/blood-2011-11-392738

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  A neonatal oral Mycobacterium tuberculosis-SIV prime / intramuscular MVA-SIV boost combination vaccine induces both SIV and Mtb-specific immune responses in infant macaques.

Authors:  Kara Jensen; Myra Grace Dela Pena; Robert L Wilson; Uma Devi K Ranganathan; William R Jacobs; Glenn Fennelly; Michelle Larsen; Koen K A Van Rompay; Pamela A Kozlowski; Kristina Abel
Journal:  Trials Vaccinol       Date:  2013-11-01

2.  Methylation and microRNA-mediated epigenetic regulation of SOCS3.

Authors:  Chandra S Boosani; Devendra K Agrawal
Journal:  Mol Biol Rep       Date:  2015-04       Impact factor: 2.316

3.  Human metapneumovirus inhibits the IL-6-induced JAK/STAT3 signalling cascade in airway epithelium.

Authors:  Dana N Mitzel; Richard J Jaramillo; Heather Stout-Delgado; Albert P Senft; Kevin S Harrod
Journal:  J Gen Virol       Date:  2013-10-10       Impact factor: 3.891

4.  E4BP4-mediated inhibition of T follicular helper cell differentiation is compromised in autoimmune diseases.

Authors:  Zijun Wang; Ming Zhao; Jinghua Yin; Limin Liu; Longyuan Hu; Yi Huang; Aiyun Liu; Jiajun Ouyang; Xiaoli Min; Shijia Rao; Wenhui Zhou; Haijing Wu; Akihiko Yoshimura; Qianjin Lu
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

5.  Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression in Mycobacterium tuberculosis infection.

Authors:  Anuradha Bandaru; Kamakshi P Devalraju; Padmaja Paidipally; Rohan Dhiman; Sambasivan Venkatasubramanian; Peter F Barnes; Ramakrishna Vankayalapati; Vijayalakshmi Valluri
Journal:  Eur J Immunol       Date:  2014-04-23       Impact factor: 5.532

6.  Constitutive STAT3 phosphorylation and IL-6/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients.

Authors:  Kirstin Harling; Ernest Adankwah; Alptekin Güler; Anthony Afum-Adjei Awuah; Louis Adu-Amoah; Ertan Mayatepek; Ellis Owusu-Dabo; Norman Nausch; Marc Jacobsen
Journal:  Cell Mol Immunol       Date:  2018-03-19       Impact factor: 11.530

7.  Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome.

Authors:  S R Vartoukian; W M Tilakaratne; N Seoudi; M Bombardieri; L Bergmeier; A R Tappuni; F Fortune
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

Review 8.  Molecular signatures of T-cell inhibition in HIV-1 infection.

Authors:  Marie Larsson; Esaki M Shankar; Karlhans F Che; Alireza Saeidi; Rada Ellegård; Muttiah Barathan; Vijayakumar Velu; Adeeba Kamarulzaman
Journal:  Retrovirology       Date:  2013-03-20       Impact factor: 4.602

9.  Decreased expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4⁺ T cells and peripheral blood from tuberculosis patients.

Authors:  Katja Kleinsteuber; Kerrin Heesch; Stefanie Schattling; Malte Kohns; Claudia Sander-Jülch; Gerhard Walzl; Anneke Hesseling; Ertan Mayatepek; Bernhard Fleischer; Florian M Marx; Marc Jacobsen
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  Differential cellular recognition pattern to M. tuberculosis targets defined by IFN-γ and IL-17 production in blood from TB + patients from Honduras as compared to health care workers: TB and immune responses in patients from Honduras.

Authors:  Nancy Alvarez-Corrales; Raija K Ahmed; Carol A Rodriguez; Kithiganahalli N Balaji; Rebeca Rivera; Ramakrishna Sompallae; Nalini K Vudattu; Sven E Hoffner; Alimuddin Zumla; Lelany Pineda-Garcia; Markus Maeurer
Journal:  BMC Infect Dis       Date:  2013-03-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.